Dr. Christopher George Mccarty, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 770 Broad St, East Earl, PA 17519 Phone: 717-445-4576 Fax: 717-445-4483 |
Bruce C Waskowicz, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 770 Broad Stret, East Earl, PA 17519 Phone: 717-445-4576 Fax: 717-445-4483 |
Virginia E Shafer, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 770 Broad Street, East Earl, PA 17519 Phone: 717-445-4576 Fax: 717-445-4483 |
News Archive
Roche today announced approval of the VENTANA PD-L1 (SP142) Assay by the US Food and Drug Administration as a complementary diagnostic to provide PD-L1 status on patients who are considering treatment with the FDA approved Roche immunotherapy TECENTRIQ™ (atezolizumab) for metastatic urothelial cancer (mUC).
Scientists who pioneered sequencing the genomes of cancer patients to find novel genetic changes at the root of the disease now have turned their attention to a laboratory workhorse — a mouse.
When it comes to HIV prevention and treatment, there is a growing population that is being overlooked - older adults - and implicit ageism is partially responsible for this neglect, according to a presentation at the 125th Annual Convention of the American Psychological Association.
The U.S. Food and Drug Administration (FDA) on the 25th of June 2018 approved Epidiolex oral solution that is essentially cannabidiol or the active component of marijuana or cannabis. As of now the drug is approved for use in two rare forms of epilepsy - Lennox-Gastaut syndrome and Dravet syndrome. The approval comes for individuals over two years of age.
› Verified 9 days ago